Comment on Manzoor, H. et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. Healthcare 2022, 10, 2579

Amin Tajerian

doi:10.3390/healthcare12050553

Comment on Manzoor, H. et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. Healthcare 2022, 10, 2579

Healthcare (Basel). 2024 Feb 28;12(5):553. doi: 10.3390/healthcare12050553.

Author

Amin Tajerian¹

Affiliation

¹ School of Medicine, Arak University of Medical Sciences, Arak 3819693345, Iran.

Abstract

In December 2022, the paper "Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis" was published in the Healthcare journal [...].